Skip to main content
NIH funding notice PAR-19-251

Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)

Closed on November 8, 2021.

Posted
April 11, 2019
Close date
November 8, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,143,204 in first-year total cost, median $571,602.

Most frequent study sections

  1. Cancer Etiology Study Section[CE]1
  2. Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]1

Most frequent institutions

  1. NORTHWESTERN UNIVERSITY AT CHICAGO1
  2. UNIV OF NORTH CAROLINA CHAPEL HILL1
Competing awards under PAR-19-251 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Investigating Environmental Risk Factors for Breast Cancer Using Adductomics1R01ES031809-01A1FUNK, WILLIAM ENORTHWESTERN UNIVERSITY AT CHICAGO, IL$586,581CHSA
2021DNA Adduct Detection and Repair in Mammalian Cells1R01ES033414-01SANCAR, AZIZUNIV OF NORTH CAROLINA CHAPEL HILL, NC$556,623CE

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-251: Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) | ScienceDex | ConductScience